Newsroom

Developing a Drug Costs $2.6 Billion, but not Everyone Believes This

The cost to develop a new drug and win FDA marketing approval is now pegged at nearly $2.6 billion, according to a new report from the Tufts Center for the Study of Drug Development.

Read more

Big Pharma Plays Hide-the-Ball With Data

The revelation of hidden data bolstered a growing movement against what’s referred to within the research community as “publication bias,” in which scientists squirrel away mostly negative or inconclusive findings and broadcast only their positive ones.

Read more

I Don’t Want to Say “I Told You So,” But…

The National Association of Medicaid Directors (NAMD) issued a letter to Congress last month that included a variety of interesting proposals but also raised the specter of direct or indirect price controls for the very high-priced Hepatitis drugs that are devastating state Medicaid budgets.

Read more

Express Scripts Explains Plan To Drive Down Hep C Rx Prices, Break Gilead’s Lock On Providers

The defeat of more than a half dozen sitting Democratic senators last Tuesday marks the first time since 1980 that the GOP has been able to unseat more than two incumbents in a single night.

Read more